eu gout therapeutics market

EU Gout Therapeutics Market, Market Segmented by Drug Class (NSAIDs, Corticosteroids, Colchicine, Urate-lowering agents) and by Therapeutics (Acute Gout and Chronic Gout) Growth, Trends and Forecast, 2019-2028

  • Published Date: 2022-12-26
  • Report ID: 138218
  • Pages: 200
  • Format: prudent report format

Report Overview

The EU Gout Therapeutics market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Gout is a common and complex form of arthritis that can affect anyone. It's characterized by sudden, severe attacks of pain, swelling, redness and tenderness in one or more joints, most often in the big toe. An attack of gout can occur suddenly, often waking you up in the middle of the night with the sensation that your big toe is on fire. The affected joint is hot, swollen and so tender that even the weight of the bedsheet on it may seem intolerable



Market Drivers

Increasing adoption of newer therapies further help propel the industry. Increasing aging population are more vulnerable for gout which can augment the market growth. Increasing adoption of newer therapies and advanced treatment can act as a market driver


1. EU Gout Therapeutics Market Overview.............................................
A. Market Size
2. EU Gout Therapeutics Market Growth Drivers..........................
A. Increasing adoption of newer therapies and advanced treatment
B. Increasing aging population
3. EU Gout Therapeutics Market Segmentation.
A. By Drug Class
I. NSAIDs
II. Corticosteroids
III. Colchicine
IV. Urate-lowering agents
B. By Therapeutics
I. Acute Gout
II. Chronic Gout
4. EU Gout Therapeutics Major Market Share.......................................
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. AstraZeneca Company overview, Product & Services, Strategies & Financials
B. Novartis Company overview, Product & Services, Strategies & Financials
C. GlaxoSmithKline Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Regulatory Framework
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.